49 results
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
to the extent) so converted into Equity Interests.
“ERISA” means the Employee Retirement Income Security Act of 1974, and its regulations.
“ERISA
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
(and solely to the extent) so converted into Equity Interests.
“ERISA” means the Employee Retirement Income Security Act of 1974, and its regulations … , distributions or other payments by any Wholly-Owned Subsidiary of Borrower on its Equity Interests to, or the redemption, retirement or purchase by any Wholly
8-K
EX-2.1
h3w8za54r665dc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
11jdqr8josetm9f0
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B3
nqmtzlu
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
qat dgksjth4kll61f
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
jfzib
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
tjp7bu
16 Jun 23
Business combination disclosure
8:08am
425
35ouauqg ig
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
btevzb f3q
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
o9qsyxixnrrq9j si
18 May 23
Other Events
5:02pm
424B5
b0fuqep3 qv
17 May 23
Prospectus supplement for primary offering
4:02pm
424B5
3zowatk5d4
16 May 23
Prospectus supplement for primary offering
6:07am